UBS Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.85M Buy
381,785
+116,534
+44% +$2.63M ﹤0.01% 3613
2025
Q4
$6.29M Sell
265,251
-49,351
-16% -$1.2M ﹤0.01% 3783
2025
Q3
$7.83M Buy
314,602
+182,926
+139% +$3.94M ﹤0.01% 3558
2025
Q2
$3.03M Sell
131,676
-34,287
-21% -$794K ﹤0.01% 4393
2025
Q1
$3.73M Sell
165,963
-136,072
-45% -$3.16M ﹤0.01% 4082
2024
Q4
$5.9M Buy
302,035
+242,320
+406% +$4.8M ﹤0.01% 3633
2024
Q3
$1.09M Buy
59,715
+22,408
+60% +$428K ﹤0.01% 4585
2024
Q2
$648K Sell
37,307
-69,714
-65% -$1.23M ﹤0.01% 4795
2024
Q1
$2.1M Sell
107,021
-2,610
-2% -$55.1K ﹤0.01% 3906
2023
Q4
$2.52M Buy
109,631
+76,341
+229% +$1.71M ﹤0.01% 3558
2023
Q3
$766K Sell
33,290
-22,777
-41% -$579K ﹤0.01% 4320
2023
Q2
$1.46M Sell
56,067
-21,058
-27% -$556K ﹤0.01% 3847
2023
Q1
$2.13M Buy
77,125
+62,478
+427% +$1.65M ﹤0.01% 3365
2022
Q4
$333K Buy
14,647
+3,858
+36% +$107K ﹤0.01% 5035
2022
Q3
$367K Sell
10,789
-38,876
-78% -$1.44M ﹤0.01% 4604
2022
Q2
$1.45M Buy
49,665
+44,527
+867% +$1.13M ﹤0.01% 3409
2022
Q1
$137K Sell
5,138
-8,759
-63% -$207K ﹤0.01% 5665
2021
Q4
$359K Buy
13,897
+7,980
+135% +$199K ﹤0.01% 5242
2021
Q3
$140K Buy
5,917
+1,544
+35% +$53.9K ﹤0.01% 5590
2021
Q2
$194K Buy
+4,373
New +$161K ﹤0.01% 5371

Other funds holding PRVA